EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SLC26A1 is a major determinant of sulfate homeostasis in humans

Anja Pfau, Karen I López-Cayuqueo, Nora Scherer, Matthias Wuttke, Annekatrin Wernstedt, Daniela González Fassrainer, Desiree Ec Smith, Jiddeke M van de Kamp, Katharina Ziegeler, Kai-Uwe Eckardt, Friedrich C Luft, Peter S Aronson und 3 weitere

Journal of Clinical Investigation · 2023

DOI: 10.1172/jci161849 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2023. Verfasst von Anja Pfau und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Anion Transport Proteins, Sulfates. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, German Research Foundation, DFG, Germany ́s Excellence Strategy CIBSS – EXC-2189.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sulfate plays a pivotal role in numerous physiological processes in the human body, including bone and cartilage health. A role of the anion transporter SLC26A1 (Sat1) for sulfate reabsorption in the kidney is supported by the observation of hyposulfatemia and hypersulfaturia in Slc26a1-knockout mice. The impact of SLC26A1 on sulfate homeostasis in humans remains to be defined. By combining clinical genetics, functional expression assays, and population exome analysis, we identify SLC26A1 as a sulfate transporter in humans and experimentally validate several loss-of-function alleles. Whole-exome sequencing from a patient presenting with painful perichondritis, hyposulfatemia, and renal sulfate wasting revealed a homozygous mutation in SLC26A1, which has not been previously described to the best of our knowledge. Whole-exome data analysis of more than 5,000 individuals confirmed that rare, putatively damaging SCL26A1 variants were significantly associated with lower plasma sulfate at the population level. Functional expression assays confirmed a substantial reduction in sulfate transport for the SLC26A1 mutation of our patient, which we consider to be novel, as well as for the additional variants detected in the population study. In conclusion, combined evidence from 3 complementary approaches supports SLC26A1 activity as a major determinant of sulfate homeostasis in humans. In view of recent evidence linking sulfate homeostasis with back pain and intervertebral disc disorder, our study identifies SLC26A1 as a potential target for modulation of musculoskeletal health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anion Transport ProteinsSulfatesAnimalsMiceHumansSulfate TransportersIon TransportHomeostasisMice, KnockoutAntiporters

Stichwörter der Autor:innen

CartilageEpithelial transport of ions and waterGenetic diseasesGeneticsNephrology

Substanzen

Anion Transport ProteinsSulfate TransportersSulfatesSlc26a1 protein, mouseAntiporters

Autor:innen und Institutionen

  • Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and Max-Delbrück-Centrum für Molekulare Medizin (MDC), Berlin, Germany.
  • Institute of Genetic Epidemiology, Faculty of Medicine and Medical Center and.
  • Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg, Freiburg, Germany.
  • SYNLAB MVZ Humane Genetik, Munich, Germany.
  • Metabolic Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience and.

Förderung

  • NIDDK NIH HHS
  • German Research Foundation
  • DFG, Germany ́s Excellence Strategy CIBSS – EXC-2189
  • Bayer Pharma AG
  • AstraZeneca
  • German Federal Ministry of Education and Research
  • KfH Foundation for Preventive Medicine.
  • Innovative Medicines Initiative 2 Joint Undertaking

Zitieren

APA

Pfau, A., López-Cayuqueo, K. I., Scherer, N., Wuttke, M., Wernstedt, A., González Fassrainer, D., Smith, D. E., van de Kamp, J. M., Ziegeler, K., Eckardt, K. U., Luft, F. C., Aronson, P. S., Köttgen, A., Jentsch, T. J., & Knauf, F. (2023). SLC26A1 is a major determinant of sulfate homeostasis in humans. Journal of Clinical Investigation. https://doi.org/10.1172/jci161849

Vancouver

Pfau A, López-Cayuqueo KI, Scherer N, Wuttke M, Wernstedt A, González Fassrainer D, et al. SLC26A1 is a major determinant of sulfate homeostasis in humans. Journal of Clinical Investigation. 2023. doi:10.1172/jci161849

BibTeX
@article{Pfau2023,
  author = {Pfau, Anja and López-Cayuqueo, Karen I and Scherer, Nora and Wuttke, Matthias and Wernstedt, Annekatrin and González Fassrainer, Daniela and Smith, Desiree Ec and van de Kamp, Jiddeke M and Ziegeler, Katharina and Eckardt, Kai-Uwe and Luft, Friedrich C and Aronson, Peter S and Köttgen, Anna and Jentsch, Thomas J and Knauf, Felix},
  title = {SLC26A1 is a major determinant of sulfate homeostasis in humans},
  journal = {Journal of Clinical Investigation},
  year = {2023},
  doi = {10.1172/jci161849}
}
Kostenlos starten →